Relay Therapeutics (RLAY) PT Raised to $26 at Citizens on Zovega Data

August 10, 2026 4:12 AM

Citizens analyst Silvan Turkcan raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $26.00 (from $21.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found